Cabergoline and Depression - a phase IV clinical study of FDA data
Summary:
Depression is reported as a side effect among people who take Cabergoline (cabergoline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Acromegaly.
The phase IV clinical study analyzes which people have Depression when taking Cabergoline. It is created by eHealthMe based on reports of 5,946 people who have side effects when taking Cabergoline from the FDA, and is updated regularly.
What is Cabergoline?
Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.
What is Depression?
Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.
5,946 people reported to have side effects when taking Cabergoline.
Among them, 146 people (2.46%) have Depression.
Among these 146 people:
How long have people been on Cabergoline when they have Depression? *
What is the gender of people who have Depression when taking Cabergoline? *
What is the age of people who have Depression when taking Cabergoline? *
What are other drugs people take besides Cabergoline? *
What are other side effects people have besides Depression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cabergoline and have Depression?
- Check whether Depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cabergoline:
- Cabergoline (6,257 reports)
Depression treatments and more:
- Depression (652,144 reports)
How severe was Depression and when was it recovered:
Expand to all the drugs that have ingredients of cabergoline:
- Depression and drugs with ingredients of cabergoline (275 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cabergoline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Depression:
- Depression (3,167 drugs)
Browse all the conditions that are associated with Depression:
- Depression (4,125 conditions)
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
- Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
- Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cabergoline (the active ingredients of Cabergoline) and Cabergoline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Proscar and Zoledronic - 4 seconds ago
- Drug interactions of Tizanidine Hydrochloride and Spironolactone - 6 seconds ago
- Could Prilosec Otc cause Depression? - 11 seconds ago
- Drug interactions of Zoledronic and Methylphenidate Hydrochloride - 45 seconds ago
- Drug interactions of Zoloft and Amrix - 55 seconds ago
- Drug interactions of Pacerone and Simvastatin - 56 seconds ago
- Myasthenia Gravis and Pulmonary Oedema - a minute ago
- Drug interactions of Hysingla Er and Suboxone - a minute ago
- Zocor vs. Nicotinic Acid, side effect and effectiveness comparison - a minute ago
- Could Methotrexate cause Lacrimation Decreased? - a minute ago